Live Breaking News & Updates on Oz Adler

Stay updated with breaking news from Oz adler. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

SciSparc : MitoCareX Update - Form 6-K -March 13, 2024 at 09:09 am EDT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer

. ....

United States , Tel Aviv , Oz Adler , Scisparc Ltd , Mitocarex Bio Ltd , Company Or Scisparc , Securities Exchange , Exchange Commission , Foreign Private Issuer , Securities Exchange Act , Wallenberg Street , Mitocarex Bio , Alon Silberman , Private Securities Litigation Reform Act , Annual Report , Executive Officer , Chief Financial Officer ,

SciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dosing

The SCI- 210 treatment is now available at clinical site for autism spectrum disorder clinical trial in pediatric patients, in accordance with enrollment initiation TEL AVIV, Israel, Feb. 29,. ....

Oz Adler , Company Or Scisparc , Soroka Medical Center , Exchange Commission , Scisparc Ltd , Autism Spectrum Disorder , Chief Executive Officer , Aberrant Behavior Checklist Community , Clinical Global Impressions Improvement , Tourette Syndrome , Looking Statements , Private Securities Litigation Reform Act , Annual Report ,

SciSparc Delivers Treatment for Autism Spectrum Disorder

The SCI- 210 treatment is now available at clinical site for autism spectrum disorder clinical trial in pediatric patients, in accordance with enrollment. ....

Oz Adler , Company Or Scisparc , Exchange Commission , Soroka Medical Center , Scisparc Ltd , Autism Spectrum Disorder , Chief Executive Officer , Aberrant Behavior Checklist Community , Clinical Global Impressions Improvement , Tourette Syndrome , Looking Statements , Private Securities Litigation Reform Act , Annual Report , Nasdaq Sprc , Scisparc Ltd ,

SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based Compounds

SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based Compounds
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Oz Adler , Trademark Office , Clearmind Medicine Inc , Scisparc Ltd , Company Or Scisparc , Exchange Commission , Clearmind Medicine , Patent Cooperation , United States Patent , Chief Executive Officer , Tourette Syndrome , Looking Statements , Private Securities Litigation Reform Act , Annual Report ,

What's Going On With Psychedelic Drug-Developers SciSparc And Clearmind Stock? - SciSparc (NASDAQ:SPRC)

SciSparc Ltd. and Clearmind Medicine Inc. shares are trading higher Tuesday after the companies announced the submission of three international patent applications as part of the ongoing collaboration between the companies. ....

Adi Zuloff Shani , Oz Adler , Berkshire Hathaway , Clearmind Medicine Inc , Scisparc Ltd , Benzinga Pro ,